<< Back to News

System Formulary Update
Intravenous Levothyroxine

Situation

An amendment to the thyroid products class review and formulary standardization was approved at the January 2021 System Pharmacy and Therapeutics Committee meeting.

Background

The following medications were reviewed: IV levothyroxine

 Assessment/Recommendation

Changes effective: Tuesday March 9, 2021

System P&T voted to include the following products on the UNC Health System Drug Formulary:

• Levothyroxine IV injection solution (ready-to-use)

As a result, the following products will be removed from the inpatient drug formulary:

• Levothyroxine powder for injection